These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Serum uric acid and cardiovascular risk: state of the art and perspectives. Fenech G; Rajzbaum G; Mazighi M; Blacher J Joint Bone Spine; 2014 Oct; 81(5):392-7. PubMed ID: 24565888 [TBL] [Abstract][Full Text] [Related]
46. [Asymptomatic Hyperuricemia: Treatment Approaches According to the Risk of Cardiovascular and Renal Events]. Kobalava ZD; Troitskaya EA Kardiologiia; 2021 Jan; 60(12):104-109. PubMed ID: 33522474 [TBL] [Abstract][Full Text] [Related]
47. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk. Bandukwala F; Huang M; Zaltzman JS; Nash MM; Prasad GV Am J Cardiol; 2009 Mar; 103(6):867-71. PubMed ID: 19268747 [TBL] [Abstract][Full Text] [Related]
48. [Hyperuricemia and uro-nephrological disorders]. Hurtes X; Meria P Presse Med; 2011 Sep; 40(9 Pt 1):865-8. PubMed ID: 21684106 [TBL] [Abstract][Full Text] [Related]
49. [Uric acid, cardiovascular events and renal dysfunction: a circumstantial connection?]. Petriş A; Cimpoeşu D; Petriş O; Costache I Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):407-12. PubMed ID: 23077928 [TBL] [Abstract][Full Text] [Related]
50. Hyperuricemia and chronic kidney disease: to treat or not to treat. Piani F; Sasai F; Bjornstad P; Borghi C; Yoshimura A; Sanchez-Lozada LG; Roncal-Jimenez C; Garcia GE; Hernando AA; Fuentes GC; Rodriguez-Iturbe B; Lanaspa MA; Johnson RJ J Bras Nefrol; 2021; 43(4):572-579. PubMed ID: 33704350 [TBL] [Abstract][Full Text] [Related]
51. Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease. Nishizawa H; Maeda N; Shimomura I Hypertens Res; 2022 Apr; 45(4):635-640. PubMed ID: 35046512 [TBL] [Abstract][Full Text] [Related]
52. Uric acid and the development of hypertension. Hwu CM; Lin KH Med Sci Monit; 2010 Oct; 16(10):RA224-30. PubMed ID: 20885365 [TBL] [Abstract][Full Text] [Related]
53. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015 [TBL] [Abstract][Full Text] [Related]
54. Uric acid as a cardiorenal risk factor - ready for prime-time? Patel KH; Goldsmith DJ Int J Clin Pract; 2014 Jul; 68(7):796-801. PubMed ID: 24942307 [TBL] [Abstract][Full Text] [Related]
55. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications. Puddu P; Puddu GM; Cravero E; Vizioli L; Muscari A J Cardiol; 2012 May; 59(3):235-42. PubMed ID: 22398104 [TBL] [Abstract][Full Text] [Related]
56. Hyperuricaemia: more than just a cause of gout? Katsiki N; Karagiannis A; Athyros VG; Mikhailidis DP J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):397-402. PubMed ID: 23032963 [TBL] [Abstract][Full Text] [Related]
57. Uric acid and cardiovascular risk: What genes can say. Kei A; Koutsouka F; Makri A; Elisaf M Int J Clin Pract; 2018 Jan; 72(1):. PubMed ID: 29250870 [TBL] [Abstract][Full Text] [Related]
58. Uric acid and cardiovascular risk. Parmar MS N Engl J Med; 2009 Jan; 360(5):539; author reply 540-1. PubMed ID: 19186310 [No Abstract] [Full Text] [Related]